Also trades as: MBXBF (OTC) · $vol 0M
MBX.TO TSX
Microbix Biosystems Inc.
1W: +1.7%
1M: +1.7%
3M: +0.0%
YTD: +30.4%
1Y: +27.7%
3Y: -6.2%
5Y: -53.9%
C$0.30 ($0.21)
-0.01 (-3.23%)
Weekly Expected Move ±6.6%
C$0
C$0
C$0
C$0
C$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$80K
-101.8% ▼
Capital Expenditures
$797K
+58.2% ▲
5Y CAGR: -0.4%
Free Cash Flow
-$878K
-136.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$2M
-87.0% ▼
Net Change in Cash
-$851K
-162.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $3M | $2M | -$39K | $4M | -$2M |
| Depreciation & Amort. | $822K | $1M | $1M | $2M | $2M |
| Stock-Based Comp. | $378K | $650K | $735K | $714K | $0 |
| Change in Working Capital | -$3M | -$340K | -$220K | -$2M | -$759K |
| Other Non-Cash Items | $892K | $331K | -$3M | $274K | $1M |
| Operating Cash Flow | $2M | $3M | -$1M | $4M | -$80K |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$2M | -$1M | -$2M | -$797K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $680K | $0 | $0 | -$271K | $0 |
| Investing Cash Flow | -$622K | -$2M | -$1M | -$2M | -$797K |
| — Financing Activities — | |||||
| Net Debt Issuance | $84K | -$1M | $1M | -$522K | -$848K |
| Stock Repurchased | $0 | $0 | -$1M | -$925K | -$2M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $2M | $3M | $105K | $364K | -$211K |
| Financing Cash Flow | $8M | $2M | $229K | -$1M | $27K |
| Net Change in Cash | $10M | $4M | -$2M | $1M | -$851K |
| Cash End of Period | $10M | $13M | $12M | $13M | $12M |
| Free Cash Flow | $804K | $1M | -$2M | $2M | -$878K |